June 30, 2015—The U.S. Senate Appropriations Committee included a 340B program user fee in the federal healthcare spending bill it passed last week. … [Read more...]
House Panel Level Funds 340B Program in FY 2016
Urges OPA finish work on ceiling price verification systemJune 26, 2015—The U.S. House Appropriations Committee passed its main annual domestic spending bill this week, which level funds the 340B program in the fiscal year that begins Oct. 1. … [Read more...]
HRSA Gives 340B Hospitals a Head’s Up About Recertification
Office of Pharmacy Affairs is holding a webinar on July 8June 23, 2015—The Health Resources and Services Administration Office of Pharmacy Affairs is holding a webinar on July 8 from noon to 1:00 p.m. Eastern about annual recertification of eligibility for 340B hospitals. … [Read more...]
HRSA Taps OIG to Administer 340B Manufacturer Sanctions
Comments on proposed rule are due Aug. 17June 18, 2015—The 340B program proposed rule formally published yesterday would give the Department of Health and Human Services Office of Inspector General responsibility for administering financial sanctions on drugmakers that overcharge providers knowingly and intentionally. … [Read more...]
Poll: Most Americans Say Drug Costs Are Unreasonable
76 percent of those who agree think drugmakers are mostly to blameJune 17, 2015—Almost three-quarters of Americans think the cost of prescription drugs is unreasonable, according to a new tracking poll from the Kaiser Family Foundation. About half feel there isn’t enough government regulation limiting the price of medicines. … [Read more...]
HHS Releases 340B Manufacturer Civil Monetary Penalty Proposed Rule
Regulation also clarifies calculation of 340B ceiling pricesJune 16, 2015—A proposed federal regulation implementing financial sanctions for drugmakers for overcharging 340B covered entities is due to be published in the Federal Register tomorrow. … [Read more...]
MedPAC Report Touches on 340B
Commission discusses reducing hospital reimbursement but makes no recommendationsJune 16, 2015—If policymakers were to decide to reduce Medicare payments for Part B drugs bought by 340B hospitals, they may want to let those hospitals keep a share of their 340B savings as an incentive to stay in the program, congressional Medicare policy advisers say in a new report. … [Read more...]